Aug 6 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU:
RICHTER: PHARMA REVENUES GREW BY 11% TO HUF 458BN IN H1 2025
RICHTER - FULL-YEAR GUIDANCE OF AROUND 10% INCREASE (EX-FX) IN BOTH REVENUES AND CLEAN EBIT IS MAINTAINED
RICHTER - PHARMA REVENUES GREW BY 11% YOY TO HUF 237.5BN IN Q2 2025
RICHTER - H1 2025 REVENUES TO HUF 458BN
RICHTER - NET PROFIT (ATTRIBUTABLE TO THE OWNERS OF THE PARENT) WAS HUF 120BN IN H1 2025
RICHTER - H1 2025 EBIT HUF 140.4BN
Source text: https://tinyurl.com/5n6cnb58
Further company coverage: GDRB.BU
((Reuters.Briefs@thomsonreuters.com;))